Tel Aviv, Israel

Zohar Pode

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Aummune Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zohar Pode. Retrieved from https://idiyas.com/inventor/zohar-pode-rd4hg1wb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zohar Pode: Innovator in T-Lymphocyte Binding Aptamers

Introduction

Zohar Pode is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of aptamers that target T-lymphocytes. His innovative work has the potential to impact various therapeutic applications.

Latest Patents

Zohar Pode holds a patent for T-lymphocyte binding aptamers. This patent provides methods of use for aptamers that specifically target T-lymphocytes, which are crucial components of the immune system. His work in this area is groundbreaking and showcases his expertise in the field.

Career Highlights

Zohar Pode is associated with Aummune Ltd., a company focused on advancing immunotherapy solutions. His role at Aummune Ltd. allows him to collaborate with other talented professionals in the industry. His contributions to the company and the field of biotechnology are noteworthy.

Collaborations

Zohar Pode has worked alongside colleagues such as Erez Lavi and Guy Neev. Their collaborative efforts have furthered research and development in the area of aptamer technology.

Conclusion

Zohar Pode is a distinguished inventor whose work on T-lymphocyte binding aptamers represents a significant advancement in biotechnology. His contributions continue to influence the field and hold promise for future therapeutic innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…